About: intravenous immunoglobulin

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: intravenous immunoglobulin Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

pharmaceutical drug

Attributes	Values
rdf:type	Item
description	composto chimico (it) composé chimique (fr) תרכובת (he) chemische Verbindung (de) pharmaceutical drug (en) քիմիական միացություն (hy) chemická sloučenina (cs) chemische verbinding (nl) kemia kombinaĵo (eo) związek chemiczny (pl) component quimic (oc) compost químic (ca) composto químico (gl) composto químico (pt) composto químico (pt-br) compuesto quimico (an) compuestu químicu (ast) compus chimic (ro) kemiallinen yhdiste (fi) kjemisk forbindelse (nb) konposatu kimiko (eu) مركب كيميائي (ar) کیٖمیٲیی مُرَکَب (ks) রাসায়নিক যৌগ (bn) compuesto químico (es) cheemsch Verbinnen (nds) legemiddel (nn)
rdfs:label	intravenous immunoglobulin (en) immunoglobulina intravenosa (ca) intravenøst immunglobulin (nn)
skos:prefLabel	intravenous immunoglobulin (en) immunoglobulina intravenosa (ca) intravenøst immunglobulin (nn)
name	intravenous immunoglobulin (en) immunoglobulina intravenosa (ca) intravenøst immunglobulin (nn)
has characteristic	wds:Q20801760-6E2A19CA-E0B4-4A92-9821-5BC338D43539
instance of	wds:Q20801760-951C1A26-FCCF-4F0E-862C-D2B3817BF23A
has characteristic	biopharmaceutical
instance of	type of chemical entity
subclass of	wds:Q20801760-a2784ef8-473d-4a29-5c5f-b1e265148592
subclass of	immunoglobulin
has use	wds:Q20801760-B292D86B-8529-4C88-B9AE-ECD451F35ABF
has use	medication
CAS Registry Number	wds:Q20801760-A5811929-18AB-4351-B01D-F8B5E1786ECE
EC number	wds:Q20801760-CB48BFBA-EF01-4F93-9989-8492FF2B07D2
ECHA Substance Infocard ID	wds:Q20801760-13572468-2468-1357-eca9-bdf024681357
DrugBank ID	wds:Q20801760-D12CF58E-AD2A-4757-8043-4A5ADD2356A1
CAS Registry Number	9007-83-4
EC number	232-706-1
ECHA Substance Infocard ID	100.029.720
DrugBank ID	00028
skos:altLabel	IVIG (en) IVIG (nn) IVIg (en) Ig alpha-2 chain C region (en) Immunoglobulin G (en) immune globulin (en)
legal status (medicine)	wds:Q20801760-6E043609-A376-4DE7-802C-3C039AF1B45D
legal status (medicine)	boxed warning
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q20801760
is possible treatment of	polymyositis dermatomyositis
is possible treatment of	wds:Q681160-0b1ecce3-4fee-c9eb-6a7a-da1e88eaf95b wds:Q980926-69b9a303-4f64-ac75-9fcd-43fa6c2008c3
is research intervention of	Pembrolizumab, Capecitabine, and Bevacizumab in Treating Patients With Microsatellite Stable Colorectal Cancer That Is Locally Advanced, Metastatic, or Cannot Be Removed by Surgery Study of IL-22 IgG2-Fc (F-652) for Subjects With Grade II-IV Lower GI aGVHD Nevirapine Study for the Prevention of Maternal-Infant HIV Transmission in Uganda A Study Of PF-05082566 As A Single Agent And In Combination With Rituximab Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer NHS-IL12 Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers Durvalumab and Topotecan for the Treatment of Relapsed or Refractory Small Cell Lung Cancer Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial Durvalumab and Tremelimumab After Radioembolization for the Treatment of Unresectable, Locally Advanced Liver Cancer Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma COVID-19 IgG Antibodies in the Serum of Recovered Patients Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast Cancer Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin s Lymphoma Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study) APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma APG101 in Glioblastoma Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma A Study of NPT189 in Healthy Subjects A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery Bevacizumab With or Without Fosbretabulin Tromethamine in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer Study of BAY1834942 in Patients With Solid Tumors Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma Ustekinumab for the Prevention of Acute Graft Versus Host Disease After Unrelated Donor Hematopoietic Cell Transplant Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA Trial Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic Cancer Bomedemstat and Maintenance Immunotherapy for Treatment of Newly Diagnosed Extensive Stage Small Cell Lung Cancer A Study of TRU-016 in Combination With Rituximab and Bendamustine in Subjects With Relapsed Indolent Lymphoma A Study to Evaluate the Safety and Tolerability of AB154 in Participants With Advanced Malignancies

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software